Document:

Exhibit 10.7

 

PRIVATE PLACEMENT WARRANTS SUBSCRIPTION AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS
SUBSCRIPTION AGREEMENT, dated as of October 20, 2021 (as it may from time to time be amended and including all exhibits referenced herein,
this “Agreement”), is entered into by and between NewHold Investment Corp. II, a Delaware corporation (the “Company”),
and NewHold Industrial Technology Holdings LLC II, a Delaware limited liability company (the “Purchaser”).

 

WHEREAS, the Company intends
to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit consisting
of one share of the Company’s Class A common stock, par value $0.0001 per share (each, a “Share”), and one-half
of one redeemable warrant. Each whole warrant entitles the holder to purchase one Share at an exercise price of $11.50 per Share (subject
to adjustment). The Purchaser has agreed to purchase an aggregate of 5,678,676 warrants (or 6,195,205 warrants if the over-allotment option
in connection with the Public Offering is exercised in full) (the “Private Placement Warrants”), each Private Placement
Warrant entitling the holder to purchase one Share at an exercise price of $11.50 per Share (subject to adjustment).

 

NOW THEREFORE, in consideration
of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1. Authorization,
Purchase and Sale; Terms of the Private Placement Warrants.

 

A. Authorization
of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement Warrants to the
Purchaser.

 

B. Purchase
and Sale of the Private Placement Warrants. On the date of the consummation of the Public Offering, and concurrently with the consummation
thereof, or on such earlier time and date as may be mutually agreed by the Purchaser and the Company (the “Initial Closing Date”),
the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company 5,678,676 Private Placement Warrants
at a price of $1.00 per warrant for an aggregate purchase price of $5,678,676 (the “Purchase Price”), which shall be
paid by wire transfer of immediately available funds to the Company in accordance with the Company’s wiring instructions. On the
Initial Closing Date, upon payment by the Purchaser of the Purchase Price, the Company, shall either, at its option, deliver a certificate
evidencing the Private Placement Warrants purchased by the Purchaser on such date duly registered in the Purchaser’s name to the
Purchaser, or effect such delivery in book-entry form. On the date of the consummation of the closing of the over-allotment option in
connection with the Public Offering, and concurrently with the consummation thereof, or on such earlier time and date as may be mutually
agreed by the Purchaser and the Company (each such date, an “Over-allotment Closing Date”; together with the Initial
Closing Date, the “Closing Dates” and each, a “Closing Date”), the Company shall issue and sell
to the Purchaser, and the Purchaser shall purchase from the Company, up to an aggregate of 516,529 Private Placement Warrants, in the
same proportion as the amount of the over-allotment option that is exercised, at a price of $1.00 per warrant for an aggregate purchase
price of up to $516,529 (if the over-allotment option in connection with the Public Offering is exercised in full) (the “Over-allotment
Purchase Price”), which shall be paid by wire transfer of immediately available funds to the Company in accordance with the
Company’s wiring instructions. On the Over-allotment Closing Date, upon the payment by the Purchaser of the Over-allotment Purchase
Price payable by it by wire transfer of immediately available funds to the Company, the Company shall either, at its option, deliver a
certificate evidencing the Private Placement Warrants purchased by the Purchaser on such date duly registered in the Purchaser’s
name to the Purchaser, or effect such delivery in book-entry form.

 

     

     

    

 

C. Terms
of the Private Placement Warrants.

 

(i) The
Private Placement Warrants shall have their terms set forth in a warrant agreement to be entered into by the Company and a warrant agent,
in connection with the Public Offering (the “Warrant Agreement”).

 

(ii) At
or prior to the time of the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the
“Registration Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser
relating to the Private Placement Warrants and the Shares underlying the Private Placement Warrants.

 

Section 2. Representations
and Warranties of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase the Private
Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive each
Closing Date) that:

 

A. Organization
and Corporate Power. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State
of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have
a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite
corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

B. Authorization;
No Breach.

 

(i) The
execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized and approved by the
Company as of each Closing Date. This Agreement constitutes a valid and binding obligation of the Company, enforceable in accordance with
its terms. Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Private
Placement Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms.

 

(ii) The
execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement
Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment of, and compliance with, the
respective terms hereof and thereof by the Company, do not and will not as of each Closing Date (a) conflict with or result in a breach
of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security interest,
charge or encumbrance upon the Company’s capital stock or assets under, (d) result in a violation of, or (e) require any authorization,
consent, approval, exemption, action, notice, declaration or filing, in each case, by or to any court or administrative or governmental
body or agency pursuant to the certificate of incorporation or the bylaws of the Company (in effect on the date hereof or as may be amended
prior to completion of the contemplated Public Offering), or any material law, statute, rule or regulation to which the Company is subject,
or any agreement, order, judgment or decree to which the Company is subject, except for any filings required after the date hereof under
federal or state securities laws.

 

C. Title
to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Placement
Warrants will be duly and validly issued and the Shares issuable upon exercise of the Private Placement Warrants will be duly and validly
issued, fully paid and nonassessable. On the date of issuance of the Placement Warrants, the Shares issuable upon exercise of the Private
Placement Warrants shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the terms hereof
and the Warrant Agreement, the Purchaser will have good title to the Private Placement Warrants and the Shares issuable upon exercise
of such Private Placement Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions
hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and
(iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

D. Valid
Issuance. The total number of shares of all classes of capital stock which the Company has authority to issue is 51,000,000 shares
of common stock (which consist of 45,000,000 shares of the Company’s Class A Common Stock and 6,000,000 shares of the Company’s
Class B common stock, par value $0.0001 per share (the “Class B Common Stock”)) and 1,000,000 shares of the Company’s
preferred stock, par value $0.0001, per share (the “Preferred Stock”). As of the date hereof, the Company has issued and outstanding
no shares of Class A Common Stock, 5,031,250 shares of Class B Common Stock (of which up to 656,250 shares are subject to forfeiture as
described in the registration statement on Form S-1 filed by the Company in connection with the Public Offering) and no shares of Preferred
Stock. All of the issued shares of capital stock of the Company have been duly authorized, validly issued, and are fully paid and non-assessable.

 

    2

     

    

 

E. Governmental
Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required
in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any
other transactions contemplated hereby.

 

Section 3. Representations
and Warranties of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue and sell the
Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties
shall survive each Closing Date) that:

 

A. Organization
and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated
by this Agreement.

 

B. Authorization;
No Breach.

 

(i) This
Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii) The
execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser
does not and shall not as of each Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions or provisions
of any agreement, instrument, order, judgment or decree to which the Purchaser is subject that would materially impact its ability to
perform its obligations hereunder.

 

C. Investment
Representations.

 

(i) The
Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such
exercise (collectively, the “Securities”), for the Purchaser’s own account, for investment purposes only and
not with a view towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii) The
Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of
1933, as amended (the “Securities Act”).

 

(iii) The
Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and
the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv) The
Purchaser did not enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule
502(c) under the Securities Act.

 

(v) The
Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to
ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities
involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.

 

(vi) The
Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made
any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser
nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

    3

     

    

 

(vii) The
Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance
on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any
other person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with
the terms and conditions of any exemption thereunder. While such Purchaser understands that Rule 144 under the Securities Act is not available
for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers
that have been at any time previously a shell company, such Purchaser understands that Rule 144 includes an exception to this prohibition
if the following conditions are met: (i) the issuer of the securities that was formerly a shell company has ceased to be a shell company;
(ii) the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
as amended (the “Exchange Act”); (iii) the issuer of the securities has filed all Exchange Act reports and material
required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such
reports and materials), other than Form 8-K reports; and (iv) at least one year has elapsed from the time that the issuer filed current
Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.

 

(viii) The
Purchaser understands the high degree of risk associated with investments in the securities of companies in the development stage such
as the Company, has such knowledge and experience in financial and business matters to be able to evaluate the merits and risks of an
investment in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder
for an indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and
will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser
can afford a complete loss of its investment in the Securities.

 

Section 4. Conditions of
the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for the Private Placement Warrants are
subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A. Representations
and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct at and as of such
Closing Date as though then made.

 

B. Performance.
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before such Closing Date.

 

C. No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

D. Warrant
Agreement and Registration Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration Rights
Agreement, each on terms satisfactory to the Purchaser.

 

E. Corporate
Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance
of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

    4

     

    

 

Section 5. Conditions of
the Company’s Obligations. The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment,
on or before each Closing Date, of each of the following conditions:

 

A. Representations
and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at and as of
such Closing Date as though then made.

 

B. Performance.
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before such Closing Date.

 

C. Corporate
Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance
of this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

D. No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

E. Warrant
Agreement. The Company shall have entered into the Warrant Agreement on terms satisfactory to the Company.

 

Section 6. Termination. This
Agreement may be terminated at any time after November 30, 2021 upon the election by either the Company or the Purchaser upon written
notice to the other party if the closing of the Public Offering does not occur prior to such date.

 

Section 7. Survival of
Representations and Warranties. All of the representations and warranties contained herein shall survive each Closing Date.

 

Section 8. Definitions. Terms
used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the registration statement on Form S-1
that the Company has filed with the Securities and Exchange Commission under the Securities Act in connection with the Public Offering.

 

Section 9. Miscellaneous.

 

A. Successors
and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf
of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed
or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement without the prior
written consent of the other party hereto, other than assignments by the Purchaser to affiliates thereof (including, without limitation,
one or more of its members).

 

B. Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C. Counterparts.
This Agreement may be executed simultaneously in two or more counterparts, none of which needs to contain the signatures of more than
one party, but all such counterparts taken together shall constitute one and the same agreement. In the event that any signature is delivered
by facsimile transmission or by e-mail delivery of a “pdf” format data file, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile
or “.pdf” signature page were an original thereof.

 

D. Descriptive
Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive
part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather than by limitation.

 

E. Governing
Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed
in accordance with the internal laws of the State of New York without regard to the conflicts of laws principles thereof.

 

F. Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties
hereto.

 

[Signature Page Follows]

 

    5

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	NEWHOLD INVESTMENT CORP. II
	 	 	 
	 	By:	/s/ Kevin Charlton 
	 	Name:	Kevin Charlton
	 	Title:	Chief Executive Officer
	 	 	 
	 	PURCHASER:
	 	
    NEWHOLD INDUSTRIAL TECHNOLOGY HOLDINGS LLC II

     

    By: NewHold Enterprises LLC, its Manager

	 	 	 
	 	By:	/s/ Kevin Charlton
	 	Name:	Kevin Charlton
	 	Title:	Co-Chairman

 

[Signature Page to Private Placement Warrants Subscription
Agreement]

 

6Exhibit 10.8

 

THE
SECURITIES DESCRIBED HEREIN HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER
JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.

 

THE
PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS
OF THEIR ENTIRE INVESTMENT.

 

SUBSCRIPTION
AGREEMENT

 

This
Subscription Agreement (this “Agreement”) is entered into as of October 20, 2021 between NewHold Investment Corp.
II, a Delaware corporation (the “Company”), NewHold Industrial Technology Holdings LLC II, a Delaware limited liability
company (the “Sponsor”) and the accounts listed in Schedule B attached hereto acting by and through UBS O’Connor
LLC and Magnetar Financial LLC (each a “Purchaser”).

 

RECITALS

 

WHEREAS,
the Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization,
reorganization or similar business combination with one or more businesses (a “Business Combination”);

 

WHEREAS,
the Company has filed with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-1
(the “Registration Statement”) for its initial public offering (“IPO”) of units (the “Public
Units”), at a price of $10.00 per Public Unit, each Public Unit comprised of one share of the Company’s Class A common
stock, par value $0.0001 per share (“Class A Common Stock”, and the shares of Class A Common Stock included in the
Public Units, the “Public Shares”), and one-half of one redeemable warrant, where each whole warrant is initially
exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share, subject to adjustment (the “Warrants”,
and the Warrants included in the Public Units, the “Public Warrants”);

 

WHEREAS,
proceeds from the IPO and the sale of the Private Placement Warrants (as defined below) in an aggregate amount equal to the aggregate
gross proceeds from the IPO will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust
Account”), as described in the Registration Statement;

 

WHEREAS,
following the closing of the IPO (the “IPO Closing”), the Company will seek to identify and consummate a Business
Combination;

 

WHEREAS,
in connection with the IPO, the Sponsor and the Purchaser will purchase, in a private placement that will close simultaneously with the
IPO Closing, warrants which are identical to the Warrants (the “Private Placement Warrants”), for a purchase price
of $1.00 per Private Placement Warrant;

 

 

WHEREAS,
the parties wish to enter into this Agreement, pursuant to which the Purchaser shall subscribe for and purchase (i) a portion of
the total number of shares of Class B common stock, par value $0.0001 per share, of the Company (“Class B Common Stock”)
to be issued prior to the IPO, as set forth on Schedule A hereto (“Founder Shares”) and (ii) Private
Placement Warrants (together with the Founder Shares, the “Subscribed Securities”) . The Class A Common Stock and
Class B Common Stock are collectively referred to herein as the “Common Stock”; and

 

WHEREAS,
the Company and the Sponsor have entered into or intend to concurrently with this Agreement enter into agreements (collectively, the
“Subscription Agreements”) in the form of this Agreement with certain affiliates of the Purchaser (together with the
Purchaser, the “Subscribing Parties”) for the purchase of Founder Shares and Private Placement Warrants set forth
therein.

 

WHEREAS,
the Company, the Sponsor and the Subscribing Parties intend for the purchase of Founder Shares and Private Placement Warrants as set
forth herein to be made pursuant to Rule 506(c) of Regulation D promulgated under the Securities Act.

 

     

     

    

 

NOW,
THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for
other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree
as follows:

 

AGREEMENT

 

1.
Sale and Purchase.

 

(a) Securities.

 

(i)
Subject to the terms and conditions hereof, the Purchaser hereby irrevocably subscribes for and agrees to purchase from the Company,
and the Company agrees to issue and sell to the Purchaser, the number of Subscribed Securities set forth on Schedule A hereto
for the aggregate purchase price set forth on Schedule A hereto (the “Initial Purchase Price”). The
Purchaser acknowledges that the Subscribed Securities, and any securities of the Company that may be distributed to the Purchaser on
account of the Subscribed Securities (collectively, the “Securities”), will be subject to restrictions on transfer
as set forth in this Agreement.

 

(ii)
On the date hereof, (A) the Company shall issue to the Purchaser the number of Founder Shares set forth on Schedule A hereto,
in consideration for the Purchaser’s payment of the portion of the Initial Purchase Price applicable to such Founder Shares, as
set forth on Schedule A hereto, by wire transfer of immediately available funds or other means approved by the Company,
and (B) the Sponsor shall forfeit to the Company for cancellation, for no consideration, and have no further right, title or interest
in, an equal number of Founder Shares. If the IPO Closing has not occurred by November 30, 2021, then the Company will promptly redeem
the Purchaser’s Founder Shares issued pursuant to this Section 1(a)(ii) for a cash payment equal to the Initial Purchase Price
paid by the Purchaser in respect of such Founder Shares, and this Agreement shall terminate and be of no further force or effect.

 

(iii)
The Company shall notify the Purchaser in writing of the anticipated date of the effectiveness of the Registration Statement (the “Effective
Date”) at least three (3) Business Days (as defined below) prior to the Effective Date, and the Purchaser shall remit
the balance of the Initial Purchase Price to the Company’s transfer agent (to be held in escrow pending the IPO Closing), by wire
transfer of immediately available funds or other means approved by the Company, on the date that is one (1) Business Day prior to the
Effective Date, or such other date as the Company and the Purchaser may agree upon in writing; provided, however, that if
the actual number of Public Units offered and sold in the IPO is less than $150 million, then (x) the Purchaser shall not be obligated
to remit the balance of the Initial Purchase Price as set forth in this Section 1(a)(iii) and (y) the Company shall promptly redeem the
Purchaser’s Founder Shares issued pursuant to Section 1(a)(ii) for a cash payment equal to the Initial Purchase Price paid by the
Purchaser in respect of such Founder Shares and this Agreement shall terminate and be of no further force or effect. As used herein,
“Business Day” means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which
banking institutions are generally authorized or required by law or regulation to close in the City of New York, New York. If the IPO
Closing has not occurred by the date that is seven (7) Business Days after the date on which the Purchaser remitted the balance
of its Initial Purchase Price to the Company’s transfer agent, then, unless the Purchaser otherwise agrees in writing, the Company
will promptly cause its transfer agent to return such amounts to the Purchaser.

 

(iv)
In the event that the underwriters’ over-allotment option in connection with the IPO (the “Over-allotment Option”)
is exercised, the Purchaser agrees to purchase additional Private Placement Warrants as indicated on Schedule A at a
price of $1.00 per warrant. The Company shall notify the Purchaser in writing of the anticipated date of each closing of the exercise
of the Over-allotment Option, if any (each, an “Over-allotment Closing”) at least three (3) Business Days prior to
such Over-allotment Closing, and the Purchaser shall pay the purchase price for the Private Placement Warrants to be purchased in connection
with such Over-allotment Closing by wire transfer of immediately available funds or other means approved by the Company on that date
that is one (1) Business Day prior to such Over-allotment Closing (to be held in escrow pending such Over-allotment Closing), or such
other date as the Company and the Purchaser may agree upon in writing. If the Over-allotment Closing has not occurred by the date that
is seven (7) Business Days after the date on which the Purchaser remitted the purchase price for the Private Placement Warrants
to be purchased in connection with such Over-allotment Closing, then, unless the Purchaser otherwise agrees in writing, the Company will
promptly cause its transfer agent to return such amounts to the Purchaser.

 

    2

     

    

 

(v)
On the date of the IPO Closing, the Company shall issue to the Purchaser the number of Private Placement Warrants set forth on Schedule
A hereto. On the date of each Over-allotment Closing, if any, the Company shall issue to Purchaser the number of Private Placement
Warrants as set forth on Schedule A.

 

(b)
 Delivery of Securities.

 

(i)
The Company shall register the Purchaser as the owner of the Subscribed Securities with the Company’s transfer agent by book entry
on or prior to the date of the IPO Closing (provided that prior to the Company’s appointment of a transfer agent it shall register
the Purchaser as the owner of such securities in the Company’s stock ledger upon issuance thereof).

 

(ii)
Each register and book entry for the Securities shall contain a notation, and each certificate (if any) evidencing the Securities shall
be stamped or otherwise imprinted with a legend, in substantially the following form:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES
LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.

 

THE
SALE, PLEDGE, HYPOTHECATION, OR TRANSFER OF THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN SUBSCRIPTION
AGREEMENT BY AND AMONG THE HOLDER AND THE OTHER PARTIES THERETO. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO
THE SECRETARY OF THE COMPANY.”

 

(c) Legend
Removal. Following the expiration of the transfer restrictions set forth in Section 5(a), if the Securities are
eligible to be sold without restriction under, and without the Company being in compliance with the current public information requirements
of, Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”), or if they are registered for
resale under the Securities Act pursuant to a shelf registration statement, then at the Purchaser’s written request, the Company
will use best efforts to cause the Company’s transfer agent to remove the legend set forth in Section 1(b)(ii),
subject to compliance by the Purchaser with the reasonable and customary procedures for such removal required by the Company or its transfer
agent. In connection therewith, if required by the Company’s transfer agent, the Company will promptly cause an opinion of counsel
to be delivered to and maintained with its transfer agent, together with any other authorizations, certificates and directions required
by the transfer agent that authorize and direct the transfer agent to issue such Securities without any such legend.

 

(d)
 Registration Rights. On the Effective Date, the Company shall enter into a Registration Rights Agreement (the “Registration
Rights Agreement”) with the Sponsor, the Subscribing Parties and certain other parties thereto, in substantially the form provided
to the Purchaser prior to the date hereof. The Registration Rights Agreement shall provide the Purchaser with registration rights with
respect to the Subscribed Securities that are no less favorable to the Purchaser than the registration rights of the Sponsor set forth
therein.

 

 

    3

     

    

 

2. Forfeiture.
The Purchaser agrees that if, prior to a Business Combination, the Sponsor’s managing members deem it necessary in order to
facilitate a Business Combination by the Company for the Sponsor to forfeit, transfer, exchange or amend the terms of all or any portion
of the Founder Shares or to enter into any other arrangements with respect to the Founder Shares (including, without limitation, a transfer
of the Sponsor’s membership interests representing an interest in any of the foregoing) to facilitate the consummation of such
Business Combination, including voting in favor of any amendment to the terms of the Founder Shares (each, a “Change in Investment”),
one-half of such Change in Investment (on a percentage basis) shall apply to Purchaser with respect to a number of Founder Shares equal
to (i) the number of Founder Shares purchased pursuant to this Agreement, minus (ii) 17,500 (such number, the “Forfeitable Founder
Shares”). By way of example and without limiting the foregoing, in the event 50% of the Sponsor’s Founder Shares are forfeited
or transferred by the Sponsor as part of such Business Combination, the Purchaser shall forfeit or transfer 25% of its Forfeitable Founder
Shares on substantially the same terms and conditions as the Sponsor. None of the terms and provisions in a Change in Investment shall
apply to, adversely affect or restrict the transfer of, the Founder Shares retained by the Purchaser pursuant to this Section 2. For
the avoidance of doubt, the Purchaser shall not be required to forfeit, transfer, exchange or amend the terms of any Private Placement
Warrants in connection with a Change in Investment.

 

3. Representations
and Warranties of the Purchaser.  The Purchaser represents and warrants to the Company as follows, as of the date hereof:

 

(a)
 Organization and Power.  The Purchaser is duly organized, validly existing, and in good standing under the laws of
the jurisdiction of its formation and has all requisite power and authority to carry on its business as presently conducted and as proposed
to be conducted.

 

(b)
 Authorization.  The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed
and delivered by the Purchaser, will constitute the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser
in accordance with its terms, except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance and any other laws of general application affecting enforcement of creditors’ rights generally or (ii) as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.

 

(c) Governmental
Consents and Filings.  No consent, approval, order or authorization of, or registration, qualification, designation, declaration
or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection with the
consummation of the transactions contemplated by this Agreement, except for filings pursuant to applicable securities laws, rules or
regulations.

 

(d)
 Compliance with Other Instruments.  The execution, delivery and performance by the Purchaser of this Agreement and
the consummation by the Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i) under
any provisions of its organizational documents, (ii) under any instrument, judgment, order, writ or decree to which it is a party
or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under
any lease, agreement, contract or purchase order to which it is a party or by which it is bound or (v) under any provision of federal
or state statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)), which would have a material
adverse effect on the Purchaser’s ability to consummate the transactions contemplated by this Agreement.

 

(e) Purchase
Entirely for Own Account.  This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to
the Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired
by the Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view
to the resale or distribution of any part thereof in violation of any state or federal securities laws, and that the Purchaser has no
present intention of selling, granting any participation in, or otherwise distributing the same in violation of law. By executing this
Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement
with any Person (other than the Company) to sell, transfer or grant participations to such Person or to any third Person, with respect
to any of the Securities. For purposes of this Agreement, “Person” means an individual, a limited liability company,
a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or any government or any department
or agency thereof.

 

(f) Disclosure
of Information.  The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs
and the terms and conditions of the offering of the Securities, as well as the terms of the Company’s proposed IPO, with the Company’s
management.

 

(g) Restricted
Securities.  The Purchaser understands that the offer and sale of the Securities to the Purchaser has not been and will not
be registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which
depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations
as expressed herein. The Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal
and state securities laws and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered
with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available.
The Purchaser acknowledges that the Company has no obligation to register or qualify the Securities except pursuant to the Registration
Rights Agreement.  The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may
be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Securities,
and on requirements relating to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation
and may not be able to satisfy. The Purchaser acknowledges that the Company has confidentially submitted the Registration Statement for
its proposed IPO. The Purchaser understands that the offering of Securities and transactions contemplated hereunder are not and are not
intended to be part of the IPO, and that the Purchaser will not be able to rely on the protection of Section 11 of the Securities
Act with respect to its purchase of Securities hereunder.

 

    4

     

    

 

(h)
 No Public Market.  The Purchaser understands that no public market now exists for the Securities, and that the Company
has not made any assurances that a public market will ever exist for the Securities.

 

(i) High
Degree of Risk.  The Purchaser understands that the purchase of the Subscribed Securities involves a high degree of risk which
could cause the Purchaser to lose all or part of its investment.

 

(j)
 Qualification.  The Purchaser is (i) an accredited investor as defined in Rule 501(a) of Regulation D promulgated
under the Securities Act, or (ii) a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act).

 

(k)
 No General Solicitation.  Neither the Purchaser, nor any of its officers, directors, employees, or agents, has either
directly or indirectly, including, through a broker or finder (i) to its knowledge, engaged in any general solicitation, or (ii) published
any advertisement in connection with the offer and sale of the Securities.

 

(l) [Reserved].

 

(m)
 Adequacy of Financing. The Purchaser will, when such funds are due hereunder, have sufficient funds to satisfy its
obligations under this Agreement.

 

(o)
 No Other Representations and Warranties; Non-Reliance.  Except for the specific representations and warranties contained
in this Section 3 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any
person acting on behalf of the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”) has
made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Purchaser and this
offering, and the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations and warranties
expressly made by the Company in Section 4 of this Agreement and in any certificate or agreement delivered pursuant
hereto, the Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties that may have
been made by the Company, any person on behalf of the Company or any of the Company’s affiliates (collectively, the “Company
Parties”) with respect to the transactions contemplated hereby.

 

 

4. Representations,
Warranties and Covenants of the Company. The Company represents, warrants and covenants to the Purchaser as follows:

 

(a)
 Organization and Corporate Power.  The Company is incorporated and validly existing and in good standing as a corporation
under the laws of Delaware and has all requisite corporate power and authority to carry on its business as presently conducted and as
proposed to be conducted.

 

(b)
 Capitalization. The authorized share capital of the Company consists, as of the date hereof:

 

(i)
45,000,000 shares of Class A Common Stock, none of which are issued and outstanding;

 

(ii)
 6,000,000 shares of Class B Common Stock, 5,031,250 of which are issued and outstanding and held by the Sponsor. All of the outstanding
shares of Class B Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable
federal and state securities laws.

 

(iii)
1,000,000 shares of preferred stock, none of which are issued and outstanding.

 

    5

     

    

 

(c) Authorization. 
All corporate action required to be taken by the Company’s Board of Directors and stockholders in order to authorize the Company
to enter into this Agreement, and to issue the Subscribed Securities, has been taken on or prior to the date hereof. All action on the
part of the stockholders, directors and officers of the Company necessary for the execution and delivery of this Agreement, the performance
of all obligations of the Company under this Agreement, and the issuance and delivery of the Subscribed Securities has been taken on
or prior to the date hereof. This Agreement, when executed and delivered by the Company, shall constitute the valid and legally binding
obligation of the Company, enforceable against the Company in accordance with its terms except (i) as limited by applicable bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement
of creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies.

 

(d) Valid
Issuance of Securities.

 

(i)
The Subscribed Securities, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement,
will be validly issued and fully paid, as applicable, and free of all preemptive or similar rights, taxes, liens, encumbrances and charges
with respect to the issue thereof and restrictions on transfer other than restrictions on transfer specified under this Agreement, applicable
state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations
of the Purchaser in this Agreement and subject to the filings described in Section 4(e) below, the Subscribed
Securities will be issued in compliance with all applicable federal and state securities laws, rules and regulations.

 

(ii)
No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except
for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company Covered Person”
means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any
Person listed in the first paragraph of Rule 506(d)(1).

 

(e) IPO.

 

(i)
The Company has provided to the Purchaser, and will at all times prior to the consummation of the IPO promptly provide to the Purchaser,
copies of all correspondence sent by the Company to, or received by the Company from, the SEC.

 

(ii)
The offers and sales of securities in the IPO will be made pursuant to an effective Registration Statement and otherwise in compliance
with the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws, rules and regulations.

 

 

(f) Governmental
Consents and Filings.  Assuming the accuracy of the representations made by the Purchaser in this Agreement, no consent, approval,
order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental
authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement,
except for filings pursuant to Regulation D of the Securities Act and applicable state securities laws, if any.

 

(g) Compliance
with Other Instruments.  The execution, delivery and performance of this Agreement and the consummation of the transactions
contemplated by this Agreement will not result in any violation or default (i) under any provisions of the certificate of incorporation,
bylaws or other governing documents of the Company, (ii) under any instrument, judgment, order, writ or decree to which the Company
is a party or by which it is bound, (iii) under any note, indenture or mortgage to which the Company is a party or by which it is
bound, (iv) under any lease, agreement, contract or purchase order to which the Company is a party or by which it is bound or (v) under
any provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which
would have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement.

 

    6

     

    

 

(h) Operations.
As of the date hereof, the Company has not conducted, and prior to the IPO Closing the Company will not conduct, any operations other
than organizational activities and activities in connection with offerings of the Securities.

 

(i) Foreign
Corrupt Practices. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company
has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution,
gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment
to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision
of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment,
kickback or other unlawful payment to any foreign or domestic government official or employee.

 

(j) Compliance
with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations,
including, but not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act
of 2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any
related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

(k) Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any
of the Company’s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.

 

(l) No
General Solicitation.  Neither the Company, nor any of its officers, managers, employees, agents or members has either directly
or indirectly, including, through a broker or finder (i) engaged in any general solicitation or (ii) published any advertisement
in connection with the offer and sale of the Subscribed Securities.

 

(m) Non-Public
Information. The Company represents and warrants that none of the information conveyed to the Purchaser in connection with the transactions
contemplated by this Agreement will constitute material non-public information of the Company upon the effectiveness of the Registration
Statement.

 

(n) No
Other Representations and Warranties; Non-Reliance.  Except for the specific representations and warranties contained in this Section 4 and
in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any
other express or implied representation or warranty with respect to the Company or the offering of Securities hereunder, and the Company
Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser
in Section 3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties
specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Purchaser Parties.

 

    7

     

    

 

5. Additional
Agreements and Acknowledgements of the Purchaser.

 

(a) Transfer
Restrictions.  The Purchaser agrees that it shall not Transfer (as defined below) (i) any Founder Shares until the earlier of
(A) one year after the closing of the Business Combination (the “Business Combination Closing”) or (B) the
date following the Business Combination Closing on which the Company completes a liquidation, merger, stock exchange or other similar
transaction that results in all of the Company’s stockholders having the right to exchange their Common Stock for cash, securities
or other property (such period, the “Lock-up Period”) or (ii) any Private Placement Warrants (or any shares of Common
Stock issuable upon exercise of the Private Placement Warrants) until 30 days after the Business Combination Closing. Notwithstanding
the foregoing, if subsequent to a Business Combination, the closing price of the Class A Common Stock equals or exceeds $12.00 per share
(as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any twenty (20) trading days within
any thirty (30) trading day period commencing at least one hundred and fifty (150) days after the Business Combination Closing, the Founder
Shares shall be released from the lockup referenced in this Section 5(a). Notwithstanding the first sentence hereinabove,
Transfers of the Securities are permitted (i) to any other person or entity that holds Common Stock prior to the consummation of
the IPO; (ii) to the Company’s officers, directors or employees; (iii) in the case of an entity, as a distribution to
its partners, stockholders or members upon liquidation; (iv) in the case of an individual, by gift to a member of the individual’s
immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate family, for estate planning purposes;
(v) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (vi) in the case
of an individual, pursuant to a qualified domestic relations order; (vii) by pledges to secure obligations incurred in connection
with purchases of the Company’s securities; (viii) by private sales or transfers made in connection with the consummation
of a Business Combination at prices no greater than the price at which the applicable Securities were originally purchased; (ix) in
the event of the Company’s liquidation, bankruptcy or dissolution prior to the completion of a Business Combination; (x) to
the Purchaser’s affiliates, to any investment fund or other entity controlled or managed by the Purchaser, or to any investment
manager or investment advisor of the Purchaser or an affiliate of any such investment manager or investment advisor or to any investment
fund or other entity controlled or managed by such persons; (xi) to a nominee or custodian of a person or entity to whom a disposition
or transfer would be permissible under clauses (i) through (x) above; and (xii) pursuant to the provisions of Section 2 of
this Agreement (each of the foregoing, a “Permitted Transferee”); provided, however, that in the case of clauses (i) through
(xi), these permitted transferees must enter into a written agreement agreeing to be bound by the terms of this Agreement, including
the forfeiture provisions of Section 2 and these transfer restrictions. As used in this Agreement, “Transfer”
shall mean the (x) sale of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option to purchase
or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position (within the meaning of Section 16 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder)
with respect to, any of the Securities; (y) entry into any swap or other arrangement that transfers to another, in whole or in part,
any of the economic consequences of ownership of any of the Securities, whether any such transaction is to be settled by delivery of
such Securities, in cash or otherwise, or (z) public announcement of any intention to effect any transaction specified in clause
(x) or (y); provided further, that this Section 5(a) shall not prohibit the Purchaser from effecting a Short Sale (as defined below)
with securities that do not constitute “Securities” under this Agreement.

 

(b) Trust
Account.

 

(i)
The Purchaser hereby acknowledges that it is aware that the Company will establish the Trust Account for the benefit of its public stockholders
upon the IPO Closing. The Purchaser hereby agrees that it has no right, title, interest or claim of any kind in or to any monies held
in the Trust Account, or any other asset of the Company as a result of any liquidation of the Company, except for redemption and liquidation
rights, if any, the Purchaser may have in respect of any Public Shares held by it.

 

(ii)
The Purchaser hereby agrees that it shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”)
to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it
may have now or in the future, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public
Shares held by it. In the event the Purchaser has any Claim against the Company under this Agreement, the Purchaser shall pursue such
Claim solely against the Company and its assets outside the Trust Account and not against the property or any monies in the Trust Account,
except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it.

 

(c) No
Short Sales. The Purchaser hereby agrees that neither it, nor any person or entity acting on its behalf, will engage in any Short
Sales with respect to securities of the Company prior to the closing of the Business Combination. For purposes of this Section 5.1(c),
“Short Sales” shall include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation
SHO under the Exchange Act, and all types of direct and indirect stock pledges (other than pledges in the ordinary course of business
as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on
a total return basis).

 

    8

     

    

 

(d) Use
of Purchaser’s Name. Neither the Company nor the Sponsor will, without the prior written consent of the Purchaser in each instance,
use in advertising, publicity or otherwise the name of the Purchaser or any of its affiliates, or any director, officer or employee of
the Purchaser, nor any trade name, trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation thereof
owned by the Purchaser or its affiliates or any information relating to the business or operations of the Purchaser or its affiliates
(including, for the avoidance of doubt, any investment vehicles, funds or accounts managed thereby). Notwithstanding the foregoing, the
Company may disclose (i) Purchaser’s name and information concerning the Purchaser (A) to the extent required by law,
regulation or regulatory request, including in the Registration Statement or (B) to the Company’s lawyers, independent accountants
and to other advisors and service providers who reasonably require Purchaser’s information in connection with the provision of
services to the Company, are advised of the confidential nature of such information and are obligated to keep such information confidential,
and (ii) Purchaser’s name and the terms of this Agreement to the other Subscribing Parties. The Company and the Sponsor agree
to provide to the Purchaser for Purchaser’s review any disclosure in any registration statement, proxy statement or other document
in advance of the submission, filing or disclosure of such document in connection with the transactions contemplated by this Agreement
with respect to the Purchaser or any of its affiliates, and will not make any such submission, filing or disclosure without including
any revisions reasonably requested in writing by the Purchaser or to the extent the Purchaser has a good faith objection to such submission,
filing or disclosure.

 

(e) Stock
Exchange Listing. The Company will use commercially reasonable efforts to effect and maintain the listing of the Class A Common Stock
and Warrants on The Nasdaq Capital Market (or another national securities exchange) until the third anniversary of the Business Combination
Closing.

 

6. General
Provisions.

 

(a) Notices. 
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given
upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic
mail or facsimile (if any) during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s
next Business Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid,
specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to:
NewHold Investment Corp. II, 12141 Wickchester Lane, Suite 325, Houston, TX 77029, Attention: Charlie Baynes-Reid, Email: cbaynesreid@newholdllc.com,
with a copy to Loeb & Loeb LLP, 345 Park Ave, New York, New York 10154, Attention: Giovanni Caruso, Email: gcaruso@loeb.com.

 

All
communications to the Purchaser shall be sent to the Purchaser’s address as set forth on the signature page hereto, or to
such email address, facsimile number (if any) or address as subsequently modified by written notice given in accordance with this Section 6(a).

 

(b) No
Finder’s Fees.  Each party represents that it neither is nor will be obligated for any finder’s fee or commission
in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission
or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of
defending against such liability or asserted liability) for which the Purchaser or any of its officers, employees or representatives
are responsible. The Company agrees to indemnify and hold harmless the Purchaser from any liability for any commission or compensation
in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against
such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.

 

(c) Survival
of Representations and Warranties.  All of the representations and warranties contained herein shall survive the consummation
of the transactions contemplated by this Agreement.

 

    9

     

    

 

(d) Entire
Agreement.  This Agreement, together with any other documents, instruments and writings that are delivered pursuant hereto or
referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes
all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in
any way to the subject matter hereof or the transactions contemplated hereby.

 

(e) Successors. 
All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to
the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f) Assignments. 
Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests, or
obligations hereunder without the prior written approval of the other party.

 

(g) Counterparts. 
This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute
one and the same instrument.

 

(h) Headings. 
The section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation
of this Agreement.

 

(i) Governing
Law.  This Agreement, the entire relationship of the parties hereto, and any litigation between the parties (whether grounded
in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of
the State of New York, without giving effect to its choice of laws principles. 

 

(j) Jurisdiction. 
The parties hereby irrevocably and unconditionally (i) submit to the jurisdiction of the state courts of New York and the United
States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or
based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement
except in state courts of New York or the United States District Court for the Southern District of New York, and (iii) waive, and
agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that
this Agreement or the subject matter hereof may not be enforced in or by such court.

 

(k) WAIVER
OF JURY TRIAL.  THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS
AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY.

 

(l) Amendments. 
This Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of the Company
and the Purchaser.

 

(m) Severability. 
The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the
validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any party
hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with
its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination will have the
power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words
or phrases, and in its reduced form, such provision will then be enforceable and will be enforced.

 

(n) Expenses. 
Each of the Company and the Purchaser will bear its own costs and expenses incurred in connection with the preparation, execution and
performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents,
representatives, financial advisors, legal counsel and accountants. The Company shall be responsible for the fees of its transfer agent,
stamp taxes and all of The Depository Trust Company’s fees associated with the issuance of the Securities and the securities issuable
upon conversion or exercise of the Securities.

 

    10

     

    

 

(o) Construction. 
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent
or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of
proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference
to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated
thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including”
will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed
to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context
otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,”
and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The
parties hereto intend that each representation, warranty, and covenant contained herein will have independent significance. If any party
hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation,
warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has
not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or
covenant.

 

(p) Waiver. 
No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or
not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect
in any way any rights arising because of any prior or subsequent occurrence.

 

(q) Specific
Performance.  Each party hereto agrees that irreparable damage may occur in the event any provision of this Agreement was not
performed by the other party hereto in accordance with the terms hereof and that the such party shall be entitled to seek specific performance
of the terms hereof, in addition to any other remedy at law or equity.

 

(r) Confidentiality. 
Except as may be required by law, regulation or applicable stock exchange listing requirements (but subject in any case to the provisions
of Section 5(d) hereof), unless and until the transactions contemplated hereby and the terms hereof are publicly
announced or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose
the existence or terms of this Agreement.  Notwithstanding the foregoing, the Purchaser shall be permitted to disclose any information
to its affiliates and its and their respective directors, officers, employees, advisors, director or indirect owners, agents and representatives,
in each case so long as such person or entity has been advised of the confidentiality obligations hereunder; provided that the Purchaser
shall be liable for any breach of such confidentiality obligations by any such person or entity.

 

[Signature
page follows]

 

    11

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

	COMPANY:	 
	 	 
	NEWHOLD INVESTMENT
    CORP. II	 
	 	 
	/s/
    Kevin Charlton 	 
	Name: 	Kevin Charlton	 
	Title:  	Chief Executive Officer	 
	 	 
	SPONSOR:	 
	 	 
	NEWHOLD INDUSTRIAL
    TECHNOLOGY HOLDINGS LLC II	 
	 	 
	By:	/s/
    Kevin Charlton         	 
	Name: 	Kevin Charlton	 
	Title:  	Memeber	 

 

	PURCHASER:	 
	 	 
	The
        Accounts Listed in Schedule B attach hereto 

    acting
    by and through Magnetar Financial LLC, their investment manager/general partner/manager
	 
	 	 
	/s/
    Magnetar Financial LLC 	 

 

	Purchaser’s Address for Notices:	 
	 	 
	The Accounts Listed in Schedule B attach hereto 	 
	acting by and through UBS O’Connor LLC, their investment manager/general partner/manager	 
	 	 
	/s/ UBS O’Connor LLC	 
	 	 
	Purchaser’s Address for Notices:	 

 

    12

     

    

 

Schedule
A

 

	 	 	Number of
 Subscribed Securities	 	 	Initial Purchase Price	 
	Founder Shares*	 	 	117,500	 	 	$	583.85	 
	Private Placement Warrants**	 	 	458,312	 	 	$	458,312.00	 

 

	*	In
the event that the Over-allotment Option is not exercised, the Purchaser agrees to forfeit up to 8,338 Founder Shares, in proportion
to the amount of the Over-allotment Option not exercised.

 

	**	In
the event that the Over-allotment Option is exercised, the Purchaser agrees to purchase up to an additional $41,688.00 of Private Placement
Warrants at a price of $1.00 per warrant (or up to 41,688 Private Placement Warrants), in the same proportion as the amount of the over-allotment
option that is exercised.

 

    13

     

    

 

Schedule
B

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]